The p21 ELISA assay was used to assess the effects of MBC-005 on tumor cell expression of p21. by Bryan S. Margulies (21492667)

Subjects:

Additional questions on vaccination. by Sara Saleh (6733619)

Subjects:

The raw data file. by Sara Saleh (6733619)

Subjects:

Flowchart of the study protocol. by Min Wang (21070)

“…Moreover, contrasting with a decrease in the control group, TC group demonstrated significance increased theta oscillatory power in C3, C4, F4, P3, T7, and T8, and a significant negative correlations were observed between state anxiety and F4-θ (r = -0.31, p = 0.04), T7-θ (r = -0.43, p = 0.01), and T8-θ (r = -0.30, p = 0.05).…”

Subject characteristics (n = 45). by Min Wang (21070)

“…Moreover, contrasting with a decrease in the control group, TC group demonstrated significance increased theta oscillatory power in C3, C4, F4, P3, T7, and T8, and a significant negative correlations were observed between state anxiety and F4-θ (r = -0.31, p = 0.04), T7-θ (r = -0.43, p = 0.01), and T8-θ (r = -0.30, p = 0.05).…”

S2 File - Valorization of various lignocellulosic wastes to <i>Ganoderma lucidum</i> (Curtis) P. Karst (Reishi Mushroom) cultivation and their FT-IR assessments by Caglar Akcay (6910697)

Subjects:

S1 File - Valorization of various lignocellulosic wastes to <i>Ganoderma lucidum</i> (Curtis) P. Karst (Reishi Mushroom) cultivation and their FT-IR assessments by Caglar Akcay (6910697)

Subjects:

Principal Coordinates Analysis (PCoA) of gut bacterial (A) and fungal (B) communities in <i>C. capitata.</i> by Maria Cecilia Rasuk (4594303)

Effects of temperature increase and nitrogen deposition on plant functional diversity. by Xuemei Xiang (20756894)

Subjects:

Open field test (total distance traveled) in mice infected with ME49 and ME49∆<i>bfd2 T. gondii</i> in the chronic stage. by Xiaocheng Zhang (3140460)

Subjects:

Open field test (total distance traveled) in mice infected with ME49 and ME49∆<i>bfd2 T. gondii</i> in the acute stage. by Xiaocheng Zhang (3140460)

Subjects:

Joinpoint regression trends in crude hospitalization and mortality rates of HPV-associated cancers in Mexico (2011–2019). by Juan Carlos Orengo (21546581)

Subjects:

Distribution of HPV-associated and attributable cancer deaths by type and sex, Mexico, 2011-2019. by Juan Carlos Orengo (21546581)

Subjects:

Hospitalizations for HPV-associated and HPV-attributable cancers by type and sex in Mexico (2011-2019): total numbers, averages, and crude rates per 100,000 population. by Juan Carlos Orengo (21546581)

Subjects:

Trends in age-standardized hospitalization rates by HPV-associated cancer type and sex (2011–2019): annual percentage change and average annual percentage change. by Juan Carlos Orengo (21546581)

Subjects:

Mortality for HPV-associated and HPV-attributable cancers by type and sex in Mexico (2011-2019): total numbers, averages, and crude rates per 100,000 population. by Juan Carlos Orengo (21546581)

Subjects:

Joinpoint regression trends in age-standardized hospitalization and mortality rates of HPV-associated cancers in Mexico (2011-2019). by Juan Carlos Orengo (21546581)

Subjects:

Trends in age-standardized mortality rates by HPV-associated cancer type and sex (2011–2019): annual percentage change and average annual percentage change. by Juan Carlos Orengo (21546581)

Subjects:

Distribution of HPV-associated and attributable cancer hospitalizations by type and sex, Mexico, 2011-2019. by Juan Carlos Orengo (21546581)

Subjects:

Age distribution and median age at hospitalization and death by HPV-associated cancer type and sex, Mexico, 2011–2019. by Juan Carlos Orengo (21546581)

Subjects: